The increase in the incidence of breast cancer that has occurred during the past 50 years can neither be accounted for by the introduction of mammography for screen ing nor by known risk factors. Instead, the increased incidence has been hypoth esized to be due to exposure to endocrine disruptors such as dichlorodiphenyltri chloroethane (DDT), which were widely used from the 1940s and thus introduced into the environment. 1 This increase in breast cancer incidence should be addressed by two distinct yet complementary endeav ours, namely, improved medical care and public health policies. A new study by Cohn and colleagues shows that in utero exposure to DDT is linked to an increased risk of breast cancer later in life and will undoubt edly reinitiate the debate about the safety of DDT and other insecticides. 2 Epidemiological and experimental studies have revealed that the breast is particularly sensitive to carcinogenic insult during morphogenesis and remodelling. 3 Use of the synthetic estrogen diethylstil bestrol to prevent miscarriages is an example of this feature of breast tissue. Fetal expo sure to diethylstilbestrol results in multiple dele terious effects in the genital tract and breasts, which range from malformations to cancer. 1 These outcomes are a consequence of altered morphogenesis.
The finding that exposure to nonmuta genic, hormonally active agents during development could increase the risk of devel oping cancer was unexpected. However, eco logical develop mental biology 4 and the tissue organization field theory of carcino genesis 5 provide the theoretical foundations for such an outcome. The tissue organiza tion field theory of carcino genesis proposes that carcino genesis is morpho genesis gone awry, and posits that exposure to hormo nally active agents at the wrong time during development interferes with key mediators of morpho genesis, such as the reciprocal interactions between the mesenchyme and epithelium. These effects involve massive changes in the pattern of gene expression in both compartments, altered composition of the extracellular matrix and altered anatomy of the mammary gland. Furthermore, these effects are exacerbated by the action of ovarian and pituitary hormones during puberty and adulthood, which leads to neoplastic development ( Figure 1 ). 6 Owing to the long interval between exposure and clinical manifestation of breast cancer (the median age at diagnosis in women is 61 years 7 ), the actual effects of fetal exposure to environmental endocrine disruptors in humans are difficult to assess. This difficulty motivated the develop ment of surrogate rodent models. Rodents exposed during gestation to low doses of xeno estrogens such as bisphenol A, a chem ical to which humans are widely exposed, show altered mammary gland morpho genesis that manifests during the period of exposure and beyond. 6 During adulthood, functional and anatomical alterations are observed, encompassing increased sensi tivity to estrogens and progesterone, increased lateral branching, induction of intraductal hyperplasias, carcinoma in situ and palpable tumours. 
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are especially important and relevant to the issue of whether a strong correlation exists between experimental carcino genesis in rodents and the aetiopathogenesis of breast cancer in women. This oneofa kind case-control study involved a 54 year followup of >20,000 pregnancies and the resulting liveborn daughters. 2 In this study, the levels of DDT, other chemicals present in the technical grade formulation and DDT metabolites were measured in the serum of mothers either during pregnancy or immediately after delivery. The study found that high maternal serum levels of o,p'DDT (an isomer of DDT) predicted a fourfold increase in the daughter's risk of developing breast cancer. Most cases were estrogenreceptor and progesterone receptor positive and receptor tyrosine protein kinase erbB2 (also known as HER2)negative.
An additional relevant fact is that a sepa rate study of breast cancer incidence in the mothers of the same cohort revealed that exposure before the age of 14 years resulted in a fivefold increase in the risk of breast cancer, 8 and that the risk was greatest in women who were exposed to DDT before 4 years of age. Together, these two studies 2, 8 show that exposure to the estrogenic insec ticide DDT increases the risk of breast cancer when women are exposed during the main events of mammogenesis, which occur from fetal to pubertal development. As already mentioned, these early expo sures alter de novo breast morpho genesis and endogenous hormone levels; environ mental endocrine disruptors continue to contribute to the carcinogenic outcome by altering tissue remodelling during adult hood. In this regard, another case-control study showed that the combined effect of environ mental estrogens (that is, the 'total xeno estrogen burden') at the time of diagnosis is an important risk factor for breast cancer. 9 The clinical and epidemiological rele vance of the study by Cohn and colleagues 2 is manifold. Firstly, their study suggests that cases that are currently being diag nosed in places where the use of DDT has been discontinued might have been initi ated by developmental exposure to DDT. Secondly, their study predicts that exposure to DDT is the main culprit in the risk of breast cancer in countries where this pes ticide is still used to control malaria, thus, inviting a reevaluation of this already controversial decision. Thirdly, this study confirms in humans what has already been shown in rodent models, thus indi cating that we must consider the results of animal studies not only for understand ing the carcinogenic process, but also for developing public health policy. Fourthly, this study demonstrates that future studies on the effect of endocrine disruptors in breast cancer will be extremely difficult to perform as the delay between exposure and outcome spans 50 years. Moreover, multiple exposures to endocrine disruptors evidently work additively, 8 thus making it necessary to address the joint effects of these exposures. Finally, from a public health perspective, the study by Cohn and coworkers indicates that exposure to these hormonally active agents should be curtailed; in this regard, physicians should have a central role in educating patients to reduce their exposure.
In conclusion, we concur with the Endocrine Society public statement on endocrinedisrupting chemicals (EDCs) that there is a need "to increase under standing of effects of EDCs, including enhan cing increased basic and clinical research, invoking the precautionary prin ciple, and advocating involvement of indi vidual and scientific society stakeholders in communicating and implementing changes in public policy and awareness. " 
